AWG Regulatory Roundup — November 3, 2026
Subscribe here!
- FDA Advances Closer to Zero Initiative with Two New Draft Guidance Documents
- FDA Finalizes Mandatory Cosmetics Recall Guidance with No Substantive Changes
- FDA issues Final Guidance and Proposed Rule on NDI Identity and Safety
- FDA Publishes Annual Forecast for Planned Monograph Activities
- California’s Packaging EPR Program Advances; CAA Webinar Now Available
- AWG Exclusive Webinar: HOW TO GET IT RIGHT: Legally Launching a Medical Device in the U.S.
- Where We’ll Be
FDA Advances Closer to Zero Initiative with Two New Draft Guidance Documents
On October 22, 2026, FDA advanced its Closer to Zero initiative with two draft guidance documents aimed at reducing heavy metals and other chemical contaminants in food. The first proposes action levels for cadmium in processed foods intended for babies and young children under two years of age. FDA considers the levels achievable when manufacturers implement control measures to reduce cadmium and may consider foods exceeding these levels adulterated and subject to enforcement action. Comments are due December 22, 2026.
The second is a new Chapter 12, “Control of Chemical Hazards,” in FDA’s draft guidance on Hazard Analysis and Risk-Based Preventive Controls for Human Food (21 CFR Part 117). The draft chapter provides FDA’s current thinking on identifying and evaluating known or reasonably foreseeable chemical hazards, determining whether such hazards require preventive controls, and implementing appropriate controls, including supply chain controls where warranted. It addresses a broad range of chemical hazards, not merely environmental contaminants such as heavy metals, and applies to facilities subject to the PCHF requirements of Part 117. Comments on Chapter 12 are due January 21, 2027.
FDA will host a free webinar on both drafts on November 16, 2026.
FDA Finalizes Mandatory Cosmetics Recall Guidance with No Substantive Changes
On October 22, 2026, FDA issued its final Questions and Answers Regarding Mandatory Cosmetics Recalls: Guidance for Industry, finalizing the December 2025 draft without substantive changes. The guidance explains FDA’s mandatory recall authority under MoCRA, including the circumstances under which FDA may order a recall, the agency’s process for seeking voluntary action first, available hearing procedures, and factors considered when evaluating whether a cosmetic presents a risk of serious adverse health consequences or death. For industry, the final guidance largely confirms FDA’s previous interpretation and procedures rather than introducing new requirements or expanding FDA’s recall authority.
FDA issues Final Guidance and Proposed Rule on NDI Identity and Safety
On October 19, 2026, FDA issued a final guidance, New Dietary Ingredient (NDI) Notifications and Related Issues; Identity and Safety Information About the NDI, which addresses the identity and safety information that manufacturers and distributors should include in New Dietary Ingredient Notifications (NDINs). The guidance finalizes three sections of FDA’s 2016 revised draft guidance, covering NDI and dietary supplement identity information, history of use or other evidence of safety, and the basis for a conclusion of safety. It addresses frequently asked questions about NDIN submissions, including the types of information FDA recommends submitting and when particular studies may be appropriate. The remaining sections of the 2016 draft guidance are still under FDA review.
FDA Publishes Annual Forecast for Planned Monograph Activities
On September 30, 2026, FDA released its annual forecast of planned OTC monograph activities for the next three years. The forecast highlights public health priorities and identifies potential changes to GRASE conditions for OTC drugs. Topics include Pediatric Acetaminophen Dosing, NSAIDs and Oligohydramnios, Oral Healthcare in Infants and Children, among others.
California’s Packaging EPR Program Advances; CAA Webinar Now Available
On October 13, 2026, CalRecycle received Circular Action Alliance’s (CAA) revised producer responsibility plan under the state’s Plastic Pollution Prevention and Packaging Producer Responsibility Act (SB 54). CalRecycle has 75 days to review the plan for compliance and respond with an approval, conditional approval, disapproval, request for additional information, or timeline for a decision on approval or disapproval.
In related news, CAA hosted a webinar on October 21, 2026 explaining how program costs are developed, allocated across materials, and used to calculate producer fees. The recording may be accessed here.
AWG Exclusive Webinar: HOW TO GET IT RIGHT: Legally Launching a Medical Device in the U.S.
Join Amin Wasserman Gurnani and Hansem Global on November 10, 2026 for a practical webinar on navigating FDA regulatory requirements for launching a medical device in the U.S. The session will cover key requirements for labeling, UDI, registration and listing, marketing applications, quality systems, and medical device reporting, with strategies to minimize regulatory risk and avoid costly delays. Register here.
Where We’ll Be
Please say hello or reach out to schedule a meeting!
Jennifer Adams, ANA Masters of Advertising Law Conference, November 2-4, 2026
Jenny Singh, Compliance Science: Using Food Exposure Assessments in Prop 65 Trials webinar, November 12
Neil O’Flaherty, Radiological Society of North America Annual Meeting, November 29-December 3